Literature DB >> 24332566

Decreased adrenoceptor stimulation in heart failure rats reduces NGF expression by cardiac parasympathetic neurons.

Wohaib Hasan1, Peter G Smith2.   

Abstract

Postganglionic cardiac parasympathetic and sympathetic nerves are physically proximate in atrial cardiac tissue allowing reciprocal inhibition of neurotransmitter release, depending on demands from central cardiovascular centers or reflex pathways. Parasympathetic cardiac ganglion (CG) neurons synthesize and release the sympathetic neurotrophin nerve growth factor (NGF), which may serve to maintain these close connections. In this study we investigated whether NGF synthesis by CG neurons is altered in heart failure, and whether norepinephrine from sympathetic neurons promotes NGF synthesis. NGF and proNGF immunoreactivity in CG neurons in heart failure rats following chronic coronary artery ligation was investigated. NGF immunoreactivity was decreased significantly in heart failure rats compared to sham-operated animals, whereas proNGF expression was unchanged. Changes in neurochemistry of CG neurons included attenuated expression of the cholinergic marker vesicular acetylcholine transporter, and increased expression of the neuropeptide vasoactive intestinal polypeptide. To further investigate norepinephrine's role in promoting NGF synthesis, we cultured CG neurons treated with adrenergic receptor (AR) agonists. An 82% increase in NGF mRNA levels was detected after 1h of isoproterenol (β-AR agonist) treatment, which increased an additional 22% at 24h. Antagonist treatment blocked isoproterenol-induced increases in NGF transcripts. In contrast, the α-AR agonist phenylephrine did not alter NGF mRNA expression. These results are consistent with β-AR mediated maintenance of NGF synthesis in CG neurons. In heart failure, a decrease in NGF synthesis by CG neurons may potentially contribute to reduced connections with adjacent sympathetic nerves.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adrenergic receptor; Autonomic; Cardiac ganglion; Heart failure; Nerve growth factor; Parasympathetic

Mesh:

Substances:

Year:  2013        PMID: 24332566      PMCID: PMC4193342          DOI: 10.1016/j.autneu.2013.11.001

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  62 in total

1.  Expression of nerve growth factor (NGF) isoforms in the rat uterus during pregnancy: accumulation of precursor proNGF.

Authors:  Edgar Lobos; Claudia Gebhardt; Annett Kluge; Katharina Spanel-Borowski
Journal:  Endocrinology       Date:  2005-01-06       Impact factor: 4.736

2.  Effects of carvedilol on M2 receptors and cholinesterase-positive nerves in adriamycin-induced rat failing heart.

Authors:  Xiao-Li Xu; Wei-Jin Zang; Jun Lu; Xin-Qin Kang; Ming Li; Xiao-Jiang Yu
Journal:  Auton Neurosci       Date:  2006-06-23       Impact factor: 3.145

Review 3.  Heart rate variability and cardiac failure.

Authors:  F Lombardi; A Mortara
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

4.  Vagal postganglionic origin of vasoactive intestinal polypeptide (VIP) mediating the vagal tachycardia.

Authors:  F Markos; H M Snow
Journal:  Eur J Appl Physiol       Date:  2006-08-09       Impact factor: 3.078

5.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators.

Authors:  M T La Rovere; J T Bigger; F I Marcus; A Mortara; P J Schwartz
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

6.  Decreased vagal control over heart rate in rats with right-sided congestive heart failure: downregulation of neuronal nitric oxide synthase.

Authors:  Motoki Nihei; Jong-Kook Lee; Haruo Honjo; Kenji Yasui; Mahmud Uzzaman; Kaichiro Kamiya; Tobias Opthof; Itsuo Kodama
Journal:  Circ J       Date:  2005-04       Impact factor: 2.993

7.  NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study.

Authors:  C Culmsee; I Semkova; J Krieglstein
Journal:  Neurochem Int       Date:  1999-07       Impact factor: 3.921

8.  Parasympathetic control of cardiac sympathetic activity: normal ventricular function versus congestive heart failure.

Authors:  E R Azevedo; J D Parker
Journal:  Circulation       Date:  1999-07-20       Impact factor: 29.690

9.  'Mature' nerve growth factor is a minor species in most peripheral tissues.

Authors:  Michael A Bierl; Elizabeth E Jones; Keith A Crutcher; Lori G Isaacson
Journal:  Neurosci Lett       Date:  2005-02-01       Impact factor: 3.046

10.  Vasoactive intestinal polypeptide antagonists attenuate vagally induced tachycardia in the anesthetized dog.

Authors:  M R Hill; D W Wallick; L R Mongeon; P J Martin; M N Levy
Journal:  Am J Physiol       Date:  1995-10
View more
  4 in total

1.  Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes.

Authors:  Andrés García-García; Claudia Korn; María García-Fernández; Olivia Domingues; Javier Villadiego; Daniel Martín-Pérez; Joan Isern; José A Bejarano-García; Jacques Zimmer; José A Pérez-Simón; Juan J Toledo-Aral; Tatiana Michel; Matti S Airaksinen; Simón Méndez-Ferrer
Journal:  Blood       Date:  2018-10-25       Impact factor: 25.476

Review 2.  Triactome: neuro-immune-adipose interactions. Implication in vascular biology.

Authors:  George Nikov Chaldakov; Marco Fiore; Peter I Ghenev; Jerzy Beltowski; Gorana Ranćić; Neşe Tunçel; Luigi Aloe
Journal:  Front Immunol       Date:  2014-04-08       Impact factor: 7.561

Review 3.  Pleiotropic activity of nerve growth factor in regulating cardiac functions and counteracting pathogenesis.

Authors:  Ewa Pius-Sadowska; Bogusław Machaliński
Journal:  ESC Heart Fail       Date:  2021-01-19

4.  Endocardial Endothelial Dysfunction Progressively Disrupts Initially Anti then Pro-Thrombotic Pathways in Heart Failure Mice.

Authors:  Amanda Schoner; Christina Tyrrell; Melinda Wu; Jill M Gelow; Alicia A Hayes; Jonathan R Lindner; Kent L Thornburg; Wohaib Hasan
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.